stockrowMirum Pharmaceuticals, Inc. (MIRM) vs PTC Therapeutics, Inc. (PTCT)
- Mirum Pharmaceuticals, Inc. MIRM 93.82 +0.30%
- PTC Therapeutics, Inc. PTCT 65.55 −0.18%
Mirum Pharmaceuticals, Inc. and PTC Therapeutics, Inc. are both Biotechnology companies. Mirum Pharmaceuticals, Inc. is the larger, with a market value of $6.1B against $5.5B — 1.1× the size. Mirum Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 42.2% against −35.1%. PTC Therapeutics, Inc. has the higher net margin (−9.17% vs −134.8%) and the higher return on invested capital (17.7% vs −184.7%). Across the 16 metrics below, PTC Therapeutics, Inc. leads on 14 and Mirum Pharmaceuticals, Inc. on 2.
Valuation
Profitability
| Metric | MIRM | PTCT | Biotechnology median |
|---|---|---|---|
| Gross margin | 81.72% | 93.20% | 65.16% |
| Operating margin | (133.62%) | 12.78% | 0.00% |
| Net margin | (134.75%) | (9.17%) | 0.00% |
| Free cash flow margin | (46.04%) | (22.43%) | 0.00% |
| Return on equity | (760.01%) | 61.08% | (50.12%) |
| Return on assets | (99.78%) | (3.62%) | (45.60%) |
| Return on invested capital | (184.65%) | 17.66% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack